CELC
Celcuity Inc.
There isn't enough reported data to score CELC yet.
CELC Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
CELC's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
CELC PE Valuation
CELC has no meaningful PE right now: it lost money over the past year.
CELC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect CELC's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CELC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.71 | -$1.02 |
| Q2 2026 | -$4.30 | -$0.83 |
| Q1 2026 | -$3.90 | -$0.85 |
| Q4 2025 | -$3.79 | -$0.96 |
| Q3 2025 | -$3.69 | -$1.08 |
| Q2 2025 | -$3.47 | -$0.73 |
| Q1 2025 | -$3.05 | -$0.27 |
| Q4 2024 | -$2.83 | -$0.14 |
CELC lost $4.71 per share over the past year, a bigger loss than the year before.
CELC Quarterly Revenue
CELC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$66.2M | -$21.3M |
| Q2 2026 | -$55.5M | -$19.2M |
| Q1 2026 | -$55.3M | -$19.4M |
| Q4 2025 | -$36.5M | -$8.6M |
| Q3 2025 | -$44.9M | -$24.3M |
| Q2 2025 | -$36.3M | -$18.1M |
| Q1 2025 | -$35.9M | -$18.8M |
| Q4 2024 | -$27.8M | -$9.2M |
CELC has burned cash in almost every quarter: −$213M over the past year, against −$145M the year before.
CELC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +327K shares |
| 1 year | +16% | +7.6M shares |
| 3 years | +151% | +33.2M shares |
| 5 years | +398% | +44.1M shares |
| Available history | +439% | +44.9M shares |
CELC has 55M diluted shares, up 16% from a year ago.
CELC Net Leverage
CELC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.0 | Neutral |
| Stochastic | 29.6 | Neutral |
CELC's weekly RSI is 37 (neutral) and its Stochastic is 30 (neutral).
CELC PE vs Healthcare Sector
CELC has no meaningful PE right now: it lost money over the past year.
CELC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $67.7 | 5.2% below |
| 20 week MA | $82.0 | 22% below |
| 50 week MA | $99.2 | 35% below |
| 100 week MA | $64.5 | 0.5% below |
| 200 week MA | $39.0 | 65% above |
CELC has fallen below most of its moving averages, though it's still 65% above its 200-week average.
CELC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.86 | $10.3 | +4.5% |
| 2021 | $10.3 | $14.0 | +36% |
| 2022 | $14.0 | $12.9 | -7.9% |
| 2023 | $12.9 | $14.6 | +13% |
| 2024 | $14.6 | $13.8 | -5% |
| 2025 | $13.8 | $102.3 | +639% |
| 2026 YTD | $102.3 | $64.2 | -37% |
CELC is down 37% so far in 2026, after finishing higher in four of the previous six years.